Join to View Full Profile
736 Cambridge St.Brighton, MA 02135
Dr. Giordano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013- McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2006 - 2009
Loyola University Chicago Stritch School of MedicineClass of 2006
Certifications & Licensure
MA State Medical License 2020 - 2027
SC State Medical License 2013 - 2021
IL State Medical License 2009 - 2020
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2017
Clinical Trials
- Phase I Assay-guided Trial of Anti-inflammatory Phytochemicals in Patients With Advanced Cancer Start of enrollment: 2013 Mar 01
- Docetaxel and Lycopene in Metastatic Prostate Cancer Start of enrollment: 2013 Nov 01
- Dose Escalation Study of LEE011 in Combination With Buparlisib and Letrozole in HR+, HER2-negative Post-menopausal Women With Advanced Breast Cancer. Start of enrollment: 2014 Jun 27
Publications & Presentations
PubMed
- 1 citationsAntibody-drug conjugates for treating early-stage breast cancer: current use, anticipated evolutions.Pooja Patel, Antonio Giordano, Sara Giordano, Ilana Schlam, Sara M Tolaney
NPJ Breast Cancer. 2025-07-30 - 65 citationsImmunotherapy in Breast Cancer.Kathrin Dvir, Sara Giordano, Jose Pablo Leone
International Journal of Molecular Sciences. 2024-07-09 - 13 citationsOncotype DX results increase concordance in adjuvant chemotherapy recommendations for early-stage breast cancer.Luca Licata, Giulia Viale, Mario Giuliano, Giuseppe Curigliano, Mariana Chavez-MacGregor
NPJ Breast Cancer. 2023-06-08
Press Mentions
Improving Outcomes in Metastatic Breast Cancer Through Novel Therapies and Personalized CareFebruary 13th, 2025
Pregnancy, Breast Cancer, Postpartum Depression: A Charleston Mom Survived Them All in a YearMay 13th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
